Search Stories

Gene therapy aims to address the root cause of hemophilia B and help people produce stable and protective levels of...
The National Hemophilia Foundation’s (NHF) 74th Annual Bleeding Disorders Conference (BDC) will take place August 25-27, 2022. After two years...
La 74.° Conferencia Anual sobre Trastornos Hemorrágicos (BDC) de la Fundación Nacional de Hemofilia (National Hemophilia Foundation, NHF) tendrá lugar...
It’s 2022 and COVID-19 is, unfortunately, still around. Of course, things have gotten better, but the pandemic still trudges along...
Estamos en el año 2022 y desafortunadamente la COVID-19 sigue entre nosotros. Por supuesto, las cosas han mejorado, pero la...
When people with hemophilia develop an inhibitor—about 1/3 to 1/5 of people with severe hemophilia A and 1% to 4%...
Cuando las personas con hemofilia presentan un inhibidor (alrededor de 1/3 a 1/5 de las personas con hemofilia A grave...
Ask a Social Worker is a monthly column featuring questions from the community and answers from members of NHF’s Social...
Pregunte a un trabajador social es una columna mensual en la que aparecen preguntas de la comunidad y respuestas de...
People with hemophilia know that it requires effort and diligence to maintain a healthy lifestyle while living with a bleeding...
Las personas con hemofilia saben que se requiere esfuerzo y diligencia para mantener un estilo de vida saludable mientras se...
Challenge Accepted is a reality TV web series created by Genentech to tackle the unspoken issues of people living with...
Chat Icon
Need Information about Bleeding Disorders?
Contact The Neil Frick Resource Center (NFRC)